DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue S 1 · Volume 31 · June 1998 DOI: 10.1055/s-002-6320

Editorial

1
Müller, Walter E.: St. Johns Wort (Hypericum), the Story Goes on

Original Paper

2
Erdelmeier, C. A. J.: Hyperforin, Possibly the Major Non-Nitrogenous Secondary Metabolite of Hypericum perforatum L.
7
Chatterjee, S. S.; Nöldner, M.; Koch, E.; Erdelmeier, C.: Antidepressant Activity of Hypericum Perforatum and Hyperforin: the Neglected Possibility
16
Müller, W. E.; Singer, A.; Wonnemann, M.; Hafner, U.; Rolli, M.; Schäfer, C.: Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum Extract
22
Bhattacharya, S. K.; Chakrabarti, A.; Chatterjee, S. S.: Activity Profiles of Two Hyperforin-Containing Hypericum Extracts in Behavioral Models
30
Dimpfel, W.; Schober, F.; Mannel, M.: Effects of a Methanolic Extract and a Hyperforin-Enriched CO2 Extract of St. John's Wort (Hypericum perforatum) on Intracerebral Field Potentials in the Freely Moving Rat (Tele-Stereo-EEG)
36
Biber, A.; Fischer, H.; Römer, A.; Chatterjee, S. S.: Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers
44
Schellenberg, R.; Sauer, S.; Dimpfel, W.: Pharmacodynamic Effects of two Different Hypericum Extracts in Healthy Volunteers Measured by Quantitative EEG
54
Laakmann, G.; Schüle, C.; Baghai, T.; Kieser, M.: St. John's Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical Efficacy